Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer

Abstract Background Inflammatory myositis, such as dermatomyositis, is sometimes complicated by cancer and is recognized as cancer-associated myositis. Although some autoimmune antibodies are considered to be involved in the development of myositis in cancer patients, the precise mechanism has not b...

Full description

Bibliographic Details
Main Authors: Yuki Sato, Yoshinori Tanino, Takefumi Nikaido, Ryuichi Togawa, Takaya Kawamata, Natsumi Watanabe, Riko Sato, Ryuki Yamada, Takumi Onuma, Hikaru Tomita, Mikako Saito, Mami Rikimaru, Julia Morimoto, Yasuhito Suzuki, Hiroyuki Minemura, Junpei Saito, Kenya Kanazawa, Syoki Yamada, Yuko Hashimoto, Yoko Shibata
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Pulmonary Medicine
Subjects:
Cancer-associated myositis
Anti-TIF1-γ antibody
Seroconversion
Case report
Online Access:https://doi.org/10.1186/s12890-022-01974-4

Internet

https://doi.org/10.1186/s12890-022-01974-4

Similar Items